Cargando…

Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada

IMPORTANCE: In response to an increase in COVID-19 infection rates in Ontario, several systemic treatment (ST) regimens delivered in the adjuvant setting for breast cancer were temporarily permitted for neoadjuvant-intent to defer nonurgent breast cancer surgical procedures. OBJECTIVE: To examine th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Habbous, Steven, Tai, Xiaochen, Beca, Jaclyn M, Arias, Jessica, Raphael, Michael J., Parmar, Ambica, Crespo, Andrea, Cheung, Matthew C, Eisen, Andrea, Eskander, Antoine, Singh, Simron, Trudeau, Maureen, Gavura, Scott, Dai, Wei Fang, Irish, Jonathan, Krzyzanowska, Monika, Lapointe-Shaw, Lauren, Naipaul, Rohini, Peacock, Stuart, Yeung, Lyndee, Forbes, Leta, Chan, Kelvin K. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346546/ https://www.ncbi.nlm.nih.gov/pubmed/35917122 http://dx.doi.org/10.1001/jamanetworkopen.2022.25118

Ejemplares similares

Clinician Perspectives of COVID-19-Related Cancer Drug Funding Measures in Ontario
por: Naipaul, Rohini D., et al.
Publicado: (2021)

The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer
por: Raphael, Michael J., et al.
Publicado: (2021)

The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B‐cell lymphoma
por: Habbous, Steven, et al.
Publicado: (2020)

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration
por: Parmar, Ambica, et al.
Publicado: (2023)

Early survival for patients newly diagnosed with cancer during COVID‐19 in Ontario, Canada: A population‐based cohort study
por: Fu, Rui, et al.
Publicado: (2023)

Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer
por: Arciero, Vanessa, et al.
Publicado: (2022)

Are population‐based patient‐reported outcomes associated with overall survival in patients with advanced pancreatic cancer?
por: Dai, Wei Fang, et al.
Publicado: (2019)

Impact of cancer surgery slowdowns on patient survival during the COVID-19 pandemic: a microsimulation modelling study
por: Parmar, Ambica, et al.
Publicado: (2022)

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada
por: Dai, Wei Fang, et al.
Publicado: (2020)

Assessing the Impact of the COVID-19 Pandemic on Emergency Department Use for Patients Undergoing Cancer-Directed Surgeries
por: Eskander, Antoine, et al.
Publicado: (2022)

Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic
por: Walker, Meghan J., et al.
Publicado: (2022)

Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic: recommendations from Ontario, Canada
por: Grant, Robert C., et al.
Publicado: (2020)

Cancer Patients First Treated with Chemotherapy: Are They More Likely to Receive Surgery in the Pandemic?
por: Fu, Rui, et al.
Publicado: (2022)

Timeliness and Modality of Treatment for New Cancer Diagnoses During the COVID-19 Pandemic in Canada
por: Fu, Rui, et al.
Publicado: (2023)

Association between the COVID-19 pandemic and first cancer treatment modality: a population-based cohort study
por: Fu, Rui, et al.
Publicado: (2023)

Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study
por: Habbous, Steven, et al.
Publicado: (2022)

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis
por: Khor, Sara, et al.
Publicado: (2014)

Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces
por: Pataky, Reka E., et al.
Publicado: (2021)

The effect of the COVID-19 pandemic on hospital admissions and outpatient visits in Ontario, Canada
por: Habbous, Steven, et al.
Publicado: (2023)

Nivolumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Tertiary Centre’s Real-World Experience
por: Du, Yue (Jennifer), et al.
Publicado: (2023)

Overview of major salivary gland cancer surgery in Ontario (2003–2010)
por: Eskander, Antoine, et al.
Publicado: (2014)

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
por: Chan, Kelvin, et al.
Publicado: (2020)

TREATMENT, HEALTHCARE UTILIZATION AND OUTCOMES IN PATIENTS WITH GLIOBLASTOMA IN ONTARIO: A 10-YEAR COHORT STUDY
por: Rzadki, Kathryn, et al.
Publicado: (2023)

Nonsurgical management of resectable oral cavity cancer in the wake of COVID-19: A rapid review and meta-analysis
por: Forner, David, et al.
Publicado: (2020)

Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise
por: Dai, Wei Fang, et al.
Publicado: (2021)

CHOREOGRAPHED EXPANSION OF SERVICES RESULTS IN DECREASED PATIENT BURDEN WITHOUT COMPROMISE OF OUTCOMES: AN ASSESSMENT OF THE ONTARIO EXPERIENCE
por: Rzadki, Kathryn, et al.
Publicado: (2023)

Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non‐small cell lung cancer 2007‐2016
por: Shah, Monica, et al.
Publicado: (2020)

Variation in Diagnosis, Treatment, and Outcome of Esophageal Cancer in a Regionalized Care System in Ontario, Canada
por: Habbous, Steven, et al.
Publicado: (2021)

Preoperative Breast Magnetic Resonance Imaging: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline
por: Muradali, Derek, et al.
Publicado: (2023)

Changes in hospitalizations and emergency department respiratory viral diagnosis trends before and during the COVID-19 pandemic in Ontario, Canada
por: Habbous, Steven, et al.
Publicado: (2023)

Value‐based pricing: Toward achieving a balance between individual and population gains in health benefits
por: Parmar, Ambica, et al.
Publicado: (2019)

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization
por: Lu, Brandon, et al.
Publicado: (2023)

Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline
por: Blanchette, Phillip, et al.
Publicado: (2022)

Comparative Effectiveness and Safety of Pertuzumab and Trastuzumab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy for Treatment of Metastatic Breast Cancer
por: Dai, Wei Fang, et al.
Publicado: (2022)

The effect of diagnostic assessment programs on the diagnosis and treatment of patients with lung cancer in Ontario, Canada
por: Habbous, Steven, et al.
Publicado: (2021)

Incidence and real-world burden of brain metastases from solid tumors and hematologic malignancies in Ontario: a population-based study
por: Habbous, Steven, et al.
Publicado: (2020)

Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study
por: Beca, Jaclyn M., et al.
Publicado: (2021)

Phase-specific and lifetime costs of cancer care in Ontario, Canada
por: de Oliveira, Claire, et al.
Publicado: (2016)

Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program
por: Eisen, Andrea, et al.
Publicado: (2018)

Consultation diagnoses and procedures billed among recent graduates practicing general otolaryngology – head & neck surgery in Ontario, Canada
por: Eskander, Antoine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0k2o8n6c3k2hk11qnvbs5j5krl